Bioinformatics and clinical research evaluates CD276 expression in bladder cancer, highlighting its diagnostic and prognostic potential.
To assess CD276 expression and explore its relationship with the clinicopathological characteristics and prognosis of patients with bladder cancer.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: